Jan Hartmann About Associations Between Persistent Postoperative Anaemia and Mortality
Jan Hartmann, Chief Medical Officer at Haemonetics, reposted from Haemonetics on LinkedIn:
“Persistent Postoperative Anemia: A Prognostic Red Flag?
A recent, well-conducted retrospective study by Choi et al., published in Anaesthesia Journal, caught my attention:
- 𝗠𝗼𝗿𝘁𝗮𝗹𝗶𝘁𝘆 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲𝗱 𝟭𝟰.𝟱-𝗳𝗼𝗹𝗱 in patients who developed anemia after valvular heart surgery.
- Those with persistent anemia faced an 11-fold increase.
- In contrast, patients without anemia—before or two months after surgery—had significantly better outcomes.
These findings underscore the underappreciated prognostic value of monitoring hemoglobin recovery post-surgery. But here’s the nuance:
“The findings should not be assumed to imply that correcting postoperative anemia will improve patient survival.” This is a hypothesis-generating signal, not a call to action—yet. It highlights the urgent need for prospective studies to determine whether intervention can truly improve long-term outcomes—and what those interventions should be.”
Title: Associations between persistent postoperative anaemia and mortality 1 year after valvular heart surgery: a retrospective cohort study
Authors: Hee Won Choi, Hyun-Soo Zhang, Jae-Kwang Shim, Jin Sun Cho, Seo Hee Ko, Young Lan Kwak
Link to the article here.
Stay informed with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals